PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYNAPTIC DYSFUNCTION COMPRISING AN OXIME - Patent 1014981

(19)

(11)

EP 1 014 981 A1

(12)

(43)	Date of publication:
	05.07.2000 Bulletin 2000/27

(21)	Application number: 98902893.1

(22)	Date of filing: 05.02.1998

(51)	International Patent Classification (IPC)⁷: A61K 31/46 // (A61K31/46, 31:44)

(86)	International application number:
	PCT/CA9800/094

(87)	International publication number:
	WO 9834/615 (13.08.1998 Gazette 1998/32)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

07.02.1997 US 797251
10.02.1997 US 795247
14.02.1997 US 801801
14.02.1997 US 801802
21.02.1997 US 803719
21.02.1997 US 803721
21.02.1997 US 803722
21.02.1997 US 803723
28.02.1997 US 807273

(71)	Applicant: Synapse Pharmaceuticals International, Inc.
	Ottawa,Ontario K2A 2E6 (CA)

(72)	Inventor:
	VINER, Norman, M. Ottawa, Ontario K2A 2E6 (CA)

(74)	Representative: Burford, Anthony Frederick et al
	W.H. Beck, Greener & Co.7 Stone BuildingsLincoln's Inn London WC2A 3SZ London WC2A 3SZ (GB)

(54)	PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYNAPTIC DYSFUNCTION COMPRISING AN OXIME